EXOSOME ENTHALTEND THERAPEUTISCHE POLYPEPTIDE

European patent · EP3782646 · Deleted

Register entry

Publication number
EP3782646
Application number
EP20201528
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
May 25, 2017
Published
Feb 24, 2021
Granted
Sep 25, 2024
Deleted
Dec 23, 2025
Reason
Annual fee unpaid
IPC classes
A61K 38/00 (2006.01)
A61K 41/00 (2020.01)
A61K 47/65 (2017.01)
A61K 47/64 (2017.01)
A61K 47/69 (2017.01)
Priority
GB 201609216 25.05.2016
Divided from
EP17727325
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 23, 2025

    Deleted, fee unpaid

    Status of protective title
    Active → Cancelled
    Cancellation date
    23.12.2025
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 23.12.2025

  2. Aug 6, 2025

    Change

    Published in Swissreg on 06.08.2025

  3. Sep 25, 2024

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 25.09.2024

Parties

Holder

Evox Therapeutics Limited

Oxford Science Park Medawar Centre 2nd Floor East Building Robert Robinson Avenue, Oxford, Oxfordshire OX4 4HG, GB

Oxford University Innovation

Buxton Court 3 West Way, Oxford OX2 0JB, GB

Inventor

HEAN, Justin

Oxford, Oxfordshire OX2 7SS, GB

MAGER, Imre

Oxford OX1 2JD, GB

WOOD, Matthew

Oxford, Oxfordshire OX2 6HY, GB

EL ANDALOUSSI, Samir

14131 Huddinge, SE

WIKLANDER, Oscar

Huddinge 141 57, SE

NORDIN, Joel

11762 Stockholm, SE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.